https://zh.app/en/r/vrt-2026-08-06Zen Horizonen2026-08-06Vertiv Holdings Co: Deferred Revenue Doubled to 3.63 Billion USD After a 110 Million USD Second-Quarter Revenue Miss, While Full-Year Guidance Implies 4.33 Billion USD of Fourth-Quarter Sales https://zh.app/cn/r/vrt-2026-08-06纵横研报zh-cn2026-08-06Vertiv：递延收入翻倍至 36.3 亿美元，二季度收入短了 1.1 亿美元，全年指引隐含四季度 43.3 亿美元销售额 https://zh.app/en/r/cr-2026-08-06Zen Horizonen2026-08-06Crane Company: Aerospace Compounds on Its Own, but Four-Fifths of the Headline Growth Was Bought and 32 Times Earnings Leaves No Cushion https://zh.app/cn/r/cr-2026-08-06纵横研报zh-cn2026-08-06克瑞公司：航空航天板块自身在复利，但报表增速的五分之四是买来的，32 倍市盈率没有留下缓冲 https://zh.app/en/r/nio-2026-08-05Zen Horizonen2026-08-05NIO Inc.: Vehicle Margin Reached 18.8% and Adjusted Operating Profit Turned Positive in the First Quarter of 2026 While GAAP Operating Income Stayed Negative https://zh.app/cn/r/nio-2026-08-05纵横研报zh-cn2026-08-05蔚来汽车：2026 年第 1 季度整车毛利率达 18.8%，调整后经营利润转正，但 GAAP 经营利润仍为负 https://zh.app/en/r/mrk-2026-08-05Zen Horizonen2026-08-05Merck & Co.: KEYTRUDA and QLEX Generated 50.4% of Second-Quarter Revenue While Subcutaneous Sales Rose to 463 Million Dollars Before the 2028 Patent Cliff https://zh.app/cn/r/mrk-2026-08-05纵横研报zh-cn2026-08-05Merck：KEYTRUDA 与 QLEX 贡献第 2 季度收入的 50.4%，皮下注射剂型销售额升至 4.63 亿美元，2028 年专利悬崖在即 https://zh.app/en/r/loreal-2026-08-05Zen Horizonen2026-08-05L’Oréal: Record First-Half Margins and a Broad-Based Recovery, but 30 Times Earnings Already Prices In the China and Gucci Upside https://zh.app/cn/r/loreal-2026-08-05纵横研报zh-cn2026-08-05欧莱雅：上半年利润率创纪录、复苏面全线转正，但 30 倍市盈率已把中国与古驰的上行提前定价 https://zh.app/en/r/etn-2026-08-05Zen Horizonen2026-08-05Eaton: Record Orders and a Cleaner Post-Mobility Portfolio, but 42 Times Free Cash Flow Leaves No Conservative-Case Margin of Safety https://zh.app/cn/r/etn-2026-08-05纵横研报zh-cn2026-08-05伊顿：订单创纪录，剥离车辆业务后组合更清晰，但 42 倍自由现金流缺乏保守情景安全边际